| Document |
Document Title |
|
WO/2009/081483A1 |
Oxime esters represented by the general formula (I) which are useful as photopolymerization initiator; and photopoly- merization initiators containing the oxime esters as the active ingredient, which can be activated through efficient li...
|
|
WO/2008/149244A2 |
Disclosed are novel analogues of the natural product radicicol A of formulae I,.Ia, pi, Ha, lib and HI, pharmaceutical compositions comprising the compounds. The compounds of the invention are kinase and phosphatase inhibitors and find u...
|
|
WO/2008/141485A1 |
A process for stereoselective synthesis of lamivudine, comprising (a) glycosylation of compounds of formula (I) and cytosine or protected cytosine, separating the resulting products by crystallization to afford intermediates of formula (...
|
|
WO/2008/101976A1 |
A compound of general formula (I) : A process for preparing this compound. A fungicidal composition comprising a compound of general formula (I). A method for treating plants by applying a compound of general formula (I) or a composition...
|
|
WO/2008/098375A1 |
The invention emcompasses polyunsaturated fatty acid monoglycerides and derivatives thereof, having the formulae (I), (II), (III) and (IV), pharmaceutically acceptable salts thereof, compositions thereof and processes of preparing said c...
|
|
WO/2008/091337A1 |
The present invention provides for methods of administering a bisphosphonate active agent to a subject in need thereof. Aspects of the invention include administering the bisphosphonate active agent to the subject by a pulmonary route, w...
|
|
WO/2008/082017A1 |
Disclosed are: kotalanol which has an inhibitory activity on a glucosidase; a method for producing kotalanol or a cyclic sulfonium salt which is an analogue to kotalanol by an organic synthesis technique; a cyclic sulfonium salt produced...
|
|
WO/2008/068403A2 |
The invention relates to a new method for preparing N- [3- [ (2-methoxyphényl) sulfanyl] -2-methylpropyl] -3,4- dihydro-2H-1, 5-benzoxathiepin-3-amine.<0}
|
|
WO/2008/061029A1 |
Compounds of formula (I) and pharmaceutically acceptable salt thereof, which are modulators of secreted frizzled related protein-1, are disclosed. The compounds, and compositions containing the compounds, can be used to treat various dis...
|
|
WO/2008/052078A2 |
Compounds of formula (I) or pharmaceutically acceptable salts thereof are provided, wherein each of R1, R2, R3, R4, y, n, m, p, and Ar are as defined, and described in classes and subclasses herein, which are agonists or partial agonists...
|
|
WO/2008/035737A1 |
Disclosed is a 4-nitrobenzoyl derivative represented by the formula [I] or a salt thereof. Also disclosed is a herbicide for a rice plant, which comprises the derivative or the salt as an active ingredient. (I) wherein R1 represents a ha...
|
|
WO/2008/032463A1 |
Disclosed is a process for production of a sulfonic acid ester with high efficiency and in a high yield. The process comprises reacting a compound (a) having a sulfo group (-SO3H) with a compound (b) having a group represented by the gen...
|
|
WO/2008/008273A1 |
Provided herein is a new form of 3-fluoro-7-(2,2,2-trifluoroethoxy) phenoxathin 10,10-dioxide, which demonstrates higher stability relative to other forms of 3-fluoro-7-(2,2,2-trifluoroethoxy) phenoxathiin-10,10-dioxide. In particular, t...
|
|
WO/2008/004145A2 |
The present invention relates to 2-(3-methylbutyl)-4-propyl-l,3-oxathiane and its use as perfuming ingredients. The present invention concerns also the use of said compound in the perfumery industry as well as the compositions or article...
|
|
WO/2007/148597A1 |
Disclosed is a commercially advantageous method for producing a cyclic disulfonic acid ester with high yield. Specifically disclosed is a method for producing a cyclic disulfonic acid ester represented by the general formula (3) below, w...
|
|
WO/2007/134799A1 |
Compounds of the formula (I) in which the substituents are as defined in claim 1 are suitable for use as microbiocides. Formula (I), wherein X is oxygen or sulfur; A is a 5- or 6-membered heterocyclic ring containing one to three heteroa...
|
|
WO/2007/125736A1 |
The object is to provide a process for producing a methylene disulfonate compound at a low cost and in a simple manner. Disclosed is a process for producing a methylene disulfonate compound represented by the general formula (2), compris...
|
|
WO/2007/115639A1 |
The invention relates to chiral compounds of formula (I), methods of their preparation, and to their use in optical, electrooptical, electronic, semiconducting or luminescent components or devices.
|
|
WO/2007/108483A1 |
Disclosed is an N-2-(hetero)arylethylcarboxamide derivative represented by the general formula (I) or a salt thereof: (I) wherein R1 and R2 independently represent a hydrogen atom or the like; R3 and R4 independently represent a hydrogen...
|
|
WO/2007/097719A1 |
The present invention relates to a cyclisation process of forming a multiple ring compound from an isoprenoid compound. The cyclisation process involves reacting the isoprenoid compound with an acetal initiator under conditions sufficien...
|
|
WO/2007/060164A1 |
A compound of general formula (I). A process for preparing this compound. A fungicidal composition comprising a compound of general formula (I). A method for treating plants by applying a compound of general formula (I) or a composition ...
|
|
WO/2007/060166A1 |
A compound of general formula (I). A process for preparing this compound. A fungicidal composition comprising a compound of general formula (I). A method for treating plants by applying a compound of general formula (I) or a composition ...
|
|
WO/2007/057139A1 |
The invention relates to a fungicidally active compound of the general Formula (I): where Het is a 5- or 6-membered heterocyclic ring containing one to three heteroatoms, each independently selected from oxygen, nitrogen and sulphur, the...
|
|
WO/2007/049798A1 |
Disclosed is a compound represented by the formula (I) below and a pharmaceutically acceptable salt thereof. This compound is useful for treatment of obesity, diabetes and the like. [In the formula (I), Ar represents a benzene ring or th...
|
|
WO/2007/032362A1 |
It is intended to provide a substituted cycloalkene derivative represented by the general formula (I) which has an action of suppressing intracellular signal transduction or cell activation caused by endotoxin and a cell response such as...
|
|
WO/2007/010653A1 |
A salt molten at room temperature that does not contain any organic solvent, excelling in stability; and a display device that is improved in the durability in high-temperature environment by virtue of the use thereof. There is provided ...
|
|
WO/2006/128120A2 |
The invention provides lapachone analogs and derivatives as well as methods of use thereof. These compounds can be used in pharmaceutical compositions for the treatment or prevention of cell proliferation disorders. These compounds can a...
|
|
WO/2006/100039A1 |
Compounds of the formula (I) in which the substituents are as defined in claim 1 are suitable for use as microbiocides.
|
|
WO/2006/061215A2 |
The invention relates to novel 2-alkyl-cycloalk(en)yl-carboxamides of formula (I), in which X, s, R1, L, R2 and A are defined as cited in the description, to several methods for producing said substances and to the use of the latter for ...
|
|
WO/2006/058699A1 |
Compounds of the formula wherein the substituents are as defined in the claims, are useful as fungicides.
|
|
WO/2006/051476A1 |
Guanidine derivatives having a condensed tricyclic ring of formula 1: are disclosed, wherein U is C(O), CRaRb, O, NRa or S(O)m V is CRaRb or NRa; W is S(O)m ; wherein Ra is H, alkyl, cycloalkyl, alkenyl or aralkyl; Rb is H, alkyl, OH, OR...
|
|
WO/2006/051477A2 |
Compounds of formula (1): are disclosed, wherein V is CH2; W is S(O)m; m is the integer 0, 1 or 2; U is O, C(O), CR13R14 or NR15; where R13 is H, alkyl; R14 is H, OH, OR13 or OCOR13; R15 is H, alkyl, cycloalkyl, alkenyl, C(O)R13, C(O)OR1...
|
|
WO/2006/033438A1 |
The invention relates to a radically polymerizable sulfur-containing compound having a group represented by formula (1) and at least one selected from among groups represented by formulae (2) to (4) , a radically polymerizable sulfur-con...
|
|
WO/2006/029532A1 |
Nitrate esters and methods for mitigating neurodegeneration, affecting neuroprotection, affecting cognition enhancement, and/or preventing or mitigating tissue and/or cellular damage in a subject are described. Neurological or cognitive ...
|
|
WO/2006/025783A1 |
The invention provides compounds of formula (I) pharmaceutically acceptable salt or solvate thereof, in which R1, A1, m and A are as defined in the specification; a process for their preparation; pharmaceutical compositions containing th...
|
|
WO/2005/105764A1 |
Compounds of the formula (I): in which R, R1 and R2 are as defined in the description, the use thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions comprising them, and . processes for the...
|
|
WO/2005/103027A1 |
The invention relates to preparing derivatives of formula (1), wherein, in particular R1 and R2, identical or different, represent a hydrogen, fluorine or chlorine atom, a hydroxy group, an alkyl radical and an alkoxy radical, R3 is an a...
|
|
WO/2005/100308A1 |
The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions that include substituted biaryl-methanesulfinyl ace...
|
|
WO/2005/095424A1 |
Materials and methods for preparing P-chirogenic monophospholanes and bisphospholanes are disclosed. The methods employ stereoselective cyclization to generate the phospholane rings followed by pyramidal inversion to access a variety of ...
|
|
WO/2005/082881A1 |
A dihalogenated compound represented by the following formula (I) is reacted with a metal polysulfide represented by the following formula (II): X-R-X (I) (wherein X is halogeno and R is a C2-24 alkylene or aromatic alkylene group option...
|
|
WO/2005/080322A1 |
A novel fluorene characterized by having a fluorene skeleton to which a functional group such as a guanidino group is attached via a carbonyl group, or its salt. This compound has such an advantage as showing a high affinity particularly...
|
|
WO/2005/075411A1 |
The invention relates to novel haloalkyl carboxamides of formula (I), in which R, R1, R2, R3, R4, M and A are defined as cited in the description, to several methods for producing said substances and to their use for controlling undesira...
|
|
WO/2005/074686A1 |
The invention relates to novel carboxamides of formula (I), in which M represents a phenyl ring, pyridine ring or pyrimidine, pyridazine or pyrazine ring, respectively monosubstituted by R8, or represents a thiazole ring substituted by R...
|
|
WO/2005/057714A1 |
It is aimed to obtain a lithium secondary battery with excellent characteristics such as energy density and electromotive force, which is also excellent in cycle life and shelf life stability. Disclosed is an electrolyte solution for sec...
|
|
WO/2005/042492A1 |
The invention relates to novel 1,3-dimethylbutyl carboxanilides of formula (I), in which A, R1 and R2 are defined as cited in the description, to several methods for producing said substances, to their use for controlling undesirable mic...
|
|
WO/2005/042493A1 |
The invention relates to novel hexyl carboxanilides of formula (I), in which L, R1, R3 and A are defined as cited in the description, to several methods for producing said substances, to their use for controlling undesirable micro-organi...
|
|
WO/2005/040357A2 |
Compounds useful in the fluorescent labeling of biological materials are provided along with methods for their use and preparation.
|
|
WO/2005/040138A1 |
This invention is related to compounds of general formula (I) wherein X is oxygen or sulphur or a NR7 group; R1 is C3-C8 alkyl, or C1-C8 alkyl substituted by phenoxy or phenyl, both phenoxy or phenyl being optionally substituted by one o...
|
|
WO/2005/030738A1 |
The invention relates to an improved process for the preparation of 1,2-benzisoxazole-3-methane sulfonates and a novel compound 4-oximino-2,3-dihydrobenzoxathiin-2, 2-dioxides. The 1,2-benzisoxazole-2-methane sulfonates and 4-oximino...
|
|
WO/2005/027901A1 |
Compounds having one or more phenol moieties, novel derivatives thereof, compositions containing same and uses thereof for the treatment of amyloid-associated diseases are provided.
|
